Group 6 Copy 112
-1
Please wait...

About This Project

OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Blast off!

Browse Other Projects on Experiment

Related Projects

Birds eavesdrop on plant indirect defenses to locate insect preys

We all know that birds have a great vision, right? But what if they could also smell?! We demonstrated...

Where are all the Diamondback terrapins on Cumberland Island?

There is no previous population study that exists on the Diamondback terrapins of Cumberland Island, Georgia...

Transforming Styrofoam waste into biodegradable plastic

The primary objective of the project is to create an industrially-comparable method of producing PHA, a...

Backer Badge Funded

A biology project funded by 47 people